Nathaniel Dillonsmith
Hearing Date: 12 Nov 2024
Aralez Pharmaceuticals Canada Inc. v. Jamp Pharma Corporation and al
Hearing Date: 8 Apr 2024
Gilead Sciences, Inc. et al. v. Natco Pharma (Canada), Inc.
Hearing Date: 8 Apr 2024
Gilead Sciences, Inc. et al. v. Natco Pharma (Canada), Inc.
Hearing Date: 25 Mar 2024
GILEAD SCIENCES, INC. ET AL. v. JAMP PHARMA CORPORATON
Hearing Date: 25 Mar 2024
GILEAD SCIENCES, INC. ET AL. v. JAMP PHARMA CORPORATION
Hearing Date: 26 Feb 2024
NOVARTIS PHARMACEUTICALS CANADA INC. et Al. v. PHARMASCIENCE INC.
Hearing Date: 20 Feb 2024
Boehringer Ingelheim (Canada) Ltd. et al. v. Jamp Pharma Corporation
Hearing Date: 20 Feb 2024
Boehringer Ingelheim (Canada) Ltd. et al. v. Jamp Pharma Corporation
Hearing Date: 6 Jul 2023
Energizer Brands, LLC and Energizer Canada inc. v. Gillette Campany et al.
Showing 1 to 9 of 9 entries
Case 263 | Deals 78
Case 227 | Deals 295
Case 209 | Deals 119
Case 190 | Deals 190
Case 165 | Deals 54
09 Dec 2024
Freehold Royalties Ltd. announces $150 million equity offering to fund Midland Basin acquisition08 Dec 2024
Lundin Mining to sell Neves-Corvo and Zinkgruvan operations to Boliden for up to US$1.52 billion05 Dec 2024
KisoJi raises $57 million in Series B financing